8-K current report · filed Nov 4, 2026

CVS Health (CVS) 8-K Current Report: November 4, 2026

Item 7.01Item EX-99.1CVS overview

Short answer

CVS Health (CVS) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CVS intends to separate into two independent, publicly traded companies.

CVS Health 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • CVS intends to separate into two independent, publicly traded companies
  • Transaction structured to be tax-free for CVS and shareholders under U.S. federal income tax rules
  • Potentially significant strategic shift, creating standalone businesses with separate management and capital-allocation priorities
  • Shareholder impact depends on separation terms, timing, tax ruling, and assets assigned to each company

Item EX-99.1 · Exhibit EX-99.1

  • Planned tax-free separation by first half 2028 into CVS Health healthcare solutions and CVS Pharmacy retail operations
  • CVS Health to include Aetna, Caremark, Specialty, Oak Street Health and Signify Health
  • CVS Pharmacy to include approximately 9,000 pharmacies, mail pharmacy, MinuteClinic and Health100
  • David Joyner to lead CVS Health; Prem Shah to become CEO of CVS Pharmacy
  • Shareholders expected to receive ownership in both companies, subject to board approval and SEC registration effectiveness

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CVS Health 8-K filings

Get the next CVS 8-K as it lands

Follow CVS for push alerts, or ask the research agent what this filing means.